Latest Pradaxa news
Dabigatran May Be Better Than Warfarin After Bleeding Episode
posted December 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Dabigatran is less likely than warfarin to cause recurrent bleeding in atrial fibrillation patients who have experienced a major bleeding event, according to a study published online Dec. 1 in Stroke.
Higher Bleeding Risk Seen With Rivaroxaban Versus Dabigatran
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Rivaroxaban may pose a slightly greater risk of serious bleeding than dabigatran in patients with atrial fibrillation, according to a study published online Oct. 3 in JAMA Internal Medicine.
Editor's Recommendations
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk 
Physical Activity Reduces Stroke, Mortality, Regardless of A-Fib 
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults 
Global Findings Indicate Breast Cancer and A-Fib Incidence Frequently Overlap Related Articles
Study IDs Gaps in Hereditary Breast Cancer Risk Assessment Before Gender-Affirming Mastectomy 
Recurrence Score Elevated for Breast Cancer Diagnosed Within First Year Postpartum 
AI-Based Risk Scores From Screening Mammograms Predict Cancer Risk 
Smartphone-Based Heart Rhythm Monitoring Reduces Same-Day Cancellations Monthly Specialist Briefings
Stay Connected
